跳至主要内容
临床试验/NCT01106820
NCT01106820已完成不适用

Progressive Resistance Training vs. Relaxation for Breast Cancer Patients During Chemotherapy: A Randomized Controlled Intervention Trial to Evaluate the Biological Mechanisms and Effects of Resistance Training on Fatigue and Quality of Life

German Cancer Research Center2 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2010年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
101
试验地点
2
主要终点
Fatigue measured by Fatigue Assessment Questionnaire (FAQ)

研究概览

简要总结

The purpose of this randomized intervention study is to investigate the effects and biological mechanisms of a supervised 12-week progressive resistance training on fatigue and quality of life in breast cancer patients during chemotherapy. To determine the effect of the exercise itself beyond potential psychosocial effects due to attention by trainers or the group support, patients in the control group have a comparable training schedule (i.e. 60 min, twice a week, for 12 weeks) but with relaxation training (Jacobsen method).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • breast cancer patient after lumpectomy or mastectomy, stage I-III
  • adjuvant chemotherapy
  • BMI at least 18

排除标准

  • contraindication for exercise
  • radiotherapy during intervention period

结局指标

主要结局

Fatigue measured by Fatigue Assessment Questionnaire (FAQ)

时间窗: change between baseline and week 13 (end of intervention)

次要结局

  • Number of patients with adverse events potentially related to the resistance training(during the 12-week exercise intervention)
  • Depression measured by "Allgemeine Depressionsskala" (ADS, the German version of the Center for Epidemiological Studies Depression Scale (CES-D))(change between baseline and week 13 (end of intervention))
  • Muscle strength measured at the IsoMed2000®(change between baseline and week 13 (end of intervention))
  • Biomarker in blood, urine, and saliva(change between baseline and week 6 and 13)
  • Cardiorespiratory fitness measured by ergospirometry(change between baseline and week 13 (end of intervention))
  • Quality of Life measured by the European Organisation for Research and Treatment of Cancer questionnaire (EORTC-QLQ30/BR23)(change between baseline and week 13 (end of intervention))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Progressive Resistance Training Versus Relaxation... | 临床试验